Matt Stevenson - Publications

Journal articles

Conference proceedings papers

  • Wlodarczyk J, Hunsche E, Silberberg B, Kemp D, Anell B, Corcoran K, Minacori R, Stevenson M & Beaudet A (2016) COST-EFFECTIVENESS ANALYSIS OF SELEXIPAG VERSUS INHALED ILOPROST IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN SWEDEN. VALUE IN HEALTH, Vol. 19(7) (pp A556-A556), 29 October 2016 - 2 November 2016. View this article in WRRO
  • Tosh J, Stevenson M, Akehurst R & Strong M (2015) Simulation optimisation of Treatment Sequences for Rheumatoid arthritis. Value in Health, Vol. 18(7) (pp A343-A343)
  • Morrell J, Sutcliffe P, Stevenson M, Stevens J, Booth A, Scope A, Bessey A, Dennis C-L, Cantrell A, Barkham M, Churchill D, Henshaw C, Newstead J, Slade P, Spiby H & Stewart-Brown S (2015) Prevention of postnatal depression: a meta-analysis of interventions to prevent postnatal depression. JOURNAL OF REPRODUCTIVE AND INFANT PSYCHOLOGY, Vol. 33(3) (pp E3-E4)
  • Stevenson M, Rawdin A, Uttley L & Sutton A (2014) The Cost Effectiveness of Group Art Therapy for Patients with Non-Psychotic Mental Health Disorders in England And Wales. Value in Health, Vol. 17(7) (pp A458-A459)
  • Tosh J, Stevenson M, Strong M & Akehurst R (2014) A Framework for the Economic Evaluation of Sequential Therapies for Chronic Conditions. Value in Health, Vol. 17(7) (pp A584-A584)
  • Mason S, Kuczawski M, Teare MD, Stevenson M, Holmes M, Ramlakhan S, Goodacre S, Morris F & Harper R (2014) THE AHEAD STUDY: MANAGING ANTICOAGULATED PATIENTS WHO SUFFER HEAD INJURY. Emergency Medicine Journal, Vol. 31(9) (pp 775.1-775)
  • Kuczawski M, Mason S, Stevenson M, Holmes M, Teare MD, Ramlakhan S, Goodacre S, Morris F & Harper R (2014) ADHERENCE TO THE NICE HEAD INJURY GUIDELINES 2007 AND 2014 IN ANTICOAGULATED PATIENTS. Emergency Medicine Journal, Vol. 31(9) (pp 775.2-775)
  • Simpson EL, Wailoo A, Stevenson M, Tosh J, Hernandez M, Stevens JW, Archer R, Simpson E & EversonHock E (2014) The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards. Value in Health, Vol. 17, Issue 7, A380
  • Uttley L, Kearns B & Stevenson M (2013) SHOULD THERE BE AN OPTION TO "UNREFER" NICE SINGLE TECHNOLOGY APPRAISALS: CASE STUDY OF ARIPIPRAZOLE FOR BIPOLAR I DISORDER IN ADOLESCENTS. VALUE IN HEALTH, Vol. 16(7) (pp A615-A616)
  • Tosh J, Stevenson M & Akehurst R (2013) HEALTH ECONOMIC MODELLING OF SEQUENTIAL THERAPIES FOR RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW. VALUE IN HEALTH, Vol. 16(7) (pp A565-A565)
  • Chrosny W, Stevenson M & Munzer A (2013) COMPARISON OF MARKOV AND DISCRETE EVENT SIMULATION MODELING TECHNIQUES WITH APPLICATION TO COST EFFECTIVENESS ANALYSES. VALUE IN HEALTH, Vol. 16(7) (pp A587-A587)
  • Morgan MY, Stevenson MD & Jones ML (2012) THE CLINICAL UTILITY AND COST-EFFECTIVENESS OF NON-INVASIVE TESTS FOR DETECTING FIBROSIS IN PATIENTS WITH SUSPECTED ALCOHOL-RELATED LIVER DISEASE. GUT, Vol. 61 (pp A203-A203)
  • Thokala P & Goodacre SW (2012) COST-EFFECTIVENESS OF PRESENTATION AND DELAYED TROPONIN TESTING FOR ACUTE MYOCARDIAL INFARCTION. VALUE IN HEALTH, Vol. 15(4) (pp A69-A69)
  • Vargas-Palacios A, Stevenson M, Duenas A & Wailloo A (2011) COMPARING THE USE OF DYNAMIC AND STATIC INFECTIOUS DISEASE MODELS IN LATIN AMERICA WITH NORTH AMERICA, EUROPE, ASIA AND OTHER REGIONS.. VALUE IN HEALTH, Vol. 14(7) (pp A541-A541)
  • Rafia R, Papaioannou D, Stevenson M, Rathbone J & Woods HB (2011) EVALUATING THE COST-EFFECTIVENESS OF THE ADDITION OF RITUXIMAB TO CHEMOTHERAPY IN THE FIRST LINE TREATMENT OF FOLLICULAR LYMPHOMA PATIENTS IN THE UK. VALUE IN HEALTH, Vol. 14(7) (pp A445-A445)
  • Stevenson MD, Simpson EL, Rawdin AC & Papaioannou DE (2010) A review of discrete event simulation in National Coordinating Centre for Health Technology Assessment-funded work and a case study exploring the cost-effectiveness of testing for thrombophilia in patients presenting with an initial idiopathic venous thromboembolism.. J. Simulation, Vol. 4 (pp 14-23)
  • Soini EJ, Stevenson MD, Martikainen JA & Akehurst RL (2009) COST-UTILITY OF BOSENTAN IN THE FIRST-LINE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN FINLAND-A DISCRETE EVENT SIMULATION MODELLING. VALUE HEALTH, Vol. 12(7) (pp A335-A335)
  • Stevenson MD, Macdonald FC, Langley J & Akehurst RL (2008) Cost-effectiveness of bosentan versus epoprostenol and no active treatment when added to palliative care for UK patients with pulmonary arterial hypertension of WHO functional class III. EUROPEAN HEART JOURNAL, Vol. 29 (pp 859-859)
  • Stevenson MD, MacDonald FC, Langley J & Akehurst RL (2008) Bosentan is a cost-effective treatment for united kingdom patients with pulmonary arterial hypertension of WHO class III. VALUE HEALTH, Vol. 11(3) (pp A197-A197)
  • Stevenson MD, Rawdin AC, Karnon JD & Brennan A (2008) Clopidogrel is cost-effective compared with aspirin in United Kingdom patients with a myocardial infarction who subsequently sustain an ischaemic stroke or peripheral arterial disease event. VALUE HEALTH, Vol. 11(3) (pp A194-A195)
  • Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D in women with low dietary calcium intake. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S40)
  • Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and teriparatide in women with a prior fracture, low BMD and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S39)
  • Allder SJ, Stevenson M, Doyle C, Pandor A, Rothwell P, Venables G & Thomas SM (2004) Should we treat TIA as a medical emergency?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 75(8) (pp 1217-1217)
  • Stevenson MD, Brazier JE, Lloyd-Jones M, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and hormone replacement therapy in women with established osteoporosis and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S111-S111)
  • Stevenson MD, Lloyd-Jones M, Brazier JE, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D supplementation in women with low dietary intake of these nutrients and at risk of osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S87-S88)
  • Stevenson MD, Brazier JE, Kanis J & Lloyd-Jones M (2000) Cost-effectiveness of current treatments for established female osteoporosis. OSTEOPOROSIS INT, Vol. 11 (pp S11-S11)

Other